Blue Jet Healthcare FY26 net profit falls 18.8% to ₹2,478 million

Blue Jet Healthcare Limited reported an 18.8% decline in net profit to ₹2,478.16 million for the financial year ended March 31, 2026, compared to ₹3,052.03 million in the previous year. Revenue from operations decreased 7.9% to ₹9,423.67 million from ₹10,247.29 million in FY25, primarily driven by lower sales across its product segments including Contrast Media Intermediate and Artificial Sweeteners. The company’s total income stood at ₹10,110.15 million for the year.

The Board of Directors approved the audited standalone financial statements at its meeting held on May 25, 2026. The company has proposed a final dividend of ₹1.20 per equity share for the financial year 2025-26, amounting to ₹208.16 million, which is subject to the approval of shareholders at the ensuing Annual General Meeting. A final dividend of ₹1.20 per share for the previous year was declared and paid during the current year.

Financial Performance

The company’s earnings per share (EPS) for the year stood at ₹14.29, down from ₹17.59 in the previous year. Total expenses for FY26 increased marginally to ₹6,701.41 million from ₹6,670.14 million in the prior year. The cost of materials consumed decreased to ₹3,881.23 million from ₹5,402.45 million, while employee benefits expense rose to ₹735.35 million from ₹609.97 million.

Finance costs for the year rose significantly to ₹62.39 million compared to ₹0.98 million in the previous year, primarily due to interest on lease liabilities. Depreciation and amortisation expenses increased to ₹240.02 million from ₹177.89 million.

Operational Highlights

Blue Jet Healthcare’s cash and cash equivalents as of March 31, 2026, stood at ₹608.57 million, up from ₹329.79 million at the end of the previous year. The company generated net cash of ₹3,341.46 million from operating activities. However, net cash used in investing activities was ₹2,755.78 million, largely attributed to the purchase of investments amounting to ₹3,040.01 million.

The auditor, KKC & Associates LLP, highlighted revenue recognition as a key audit matter, noting that revenue is recognised at a point in time when control is transferred, generally coinciding with agreed customer terms. The audit report also noted that the company used accounting software operated by a third-party service provider for payroll records, for which the auditor was unable to comment on the audit trail feature's operation. Additionally, inventory records were maintained manually in spreadsheets until December 7, 2025, which lacked an audit trail feature.

Financial Metric (₹ in million)	FY26	FY25
Revenue from Operations	9,423.67	10,247.29
Net Profit	2,478.16	3,052.03
Total Expenses	6,701.41	6,670.14
Earnings Per Share (₹)	14.29	17.59

The audited financial statements are subject to adoption by the shareholders at the ensuing Annual General Meeting.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE0KBH01020/0c653189633c4045.pdf

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+8.62%	+9.83%	+33.37%	+24.76%	-31.56%	+50.96%

Blue Jet Healthcare Limited secured shareholder approval to raise funds through the issuance of equity shares and other eligible securities during its Extra-Ordinary General Meeting (EGM) held on June 17, 2026. The resolution authorizes the company to raise capital in one or more tranches to bolster financial resources for future requirements. The special resolution passed with 99.9999% of the votes in favour, reflecting strong shareholder support for the capital infusion plan.

A total of 143,893,328 votes were cast in favour of the resolution, while 134 votes were against it. The voting process combined remote e-voting and electronic voting during the meeting, with 143,893,462 votes polled in total. This represented 82.9522% of the outstanding shares. The participation was spread across different shareholder categories, with the Promoter and Promoter Group casting 138,445,696 votes, all in favour. Public Institutions accounted for 5,444,170 votes, also entirely in favour. Public Non-Institutions cast 3,596 votes, with 3,462 in favour and 134 against.

Voting Breakdown

Category	Votes Polled	Votes in Favour	Votes Against	% in Favour
Promoter and Promoter Group	138,445,696	138,445,696	0	100.0000
Public Institutions	5,444,170	5,444,170	0	100.0000
Public Non-Institutions	3,596	3,462	134	96.2736
Total	143,893,462	143,893,328	134	99.9999

Meeting Procedures

The EGM was convened at 11:00 a.m. via Video Conferencing and Other Audio Visual Means. Remote e-voting was facilitated by MUFG Intime India Private Limited, with the window open from June 14, 2026, to June 16, 2026. Ms. Nupur Gadekar, Partner at M/s. Mehta and Mehta, Practicing Company Secretaries, served as the Scrutinizer to oversee the e-voting process. The meeting concluded at 11:29 a.m. IST.